What this study adds
This is the first study to determine the full PK profile of DMT in
humans, confirming the rapid attainment of peak plasma levels and
subsequent clearance, with dose proportionality observed between
9–21.5 mg IV doses
Human cytochrome P450 isozymes 2D6 and 2C19 may contribute to the
metabolism of DMT